Name Development Level Target Family
Farnesyl pyrophosphate synthase Tclin Enzyme
Name Description
alendronic acid A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.
TCRDv4.6.0
DrugCentral Indication
DrugCentral
alendronic acid